Trial · NCT01358981
Results by group52
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 52
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Clinically Significant Adverse Effects | Part A - Placebo | 0 | participants | ||
| Number of Participants With Clinically Significant Adverse Effects | Part A - 0.5 mg LY2881835 | 0 | participants | ||
| Number of Participants With Clinically Significant Adverse Effects | Part A - 1.5 mg LY2881835 | 1 | participants | ||
| Number of Participants With Clinically Significant Adverse Effects | Part A - 4.5 mg LY2881835 | 0 | participants | ||
| Number of Participants With Clinically Significant Adverse Effects | Part A - 8.4 mg LY2881835 | 0 | participants | ||
| Number of Participants With Clinically Significant Adverse Effects | Part B - Placebo | 1 | participants | ||
| Number of Participants With Clinically Significant Adverse Effects | Part B - 8.4 mg LY2881835 | 2 | participants | ||
| Pharmacokinetics (PK): Area Under the Curve (AUC) of LY2881835 | Part A - 0.5 mg LY2881835 | 54.8 | Geometric Coefficient of Variation 39 | nanograms*hour/milliliter (ng*hr/mL) | |
| Pharmacokinetics (PK): Area Under the Curve (AUC) of LY2881835 | Part A - 1.5 mg LY2881835 | 125 | Geometric Coefficient of Variation 47 | nanograms*hour/milliliter (ng*hr/mL) | |
| Pharmacokinetics (PK): Area Under the Curve (AUC) of LY2881835 | Part A - 4.5 mg LY2881835 | 340 | Geometric Coefficient of Variation 31 | nanograms*hour/milliliter (ng*hr/mL) | |
| Pharmacokinetics (PK): Area Under the Curve (AUC) of LY2881835 | Part A - 8.4 mg LY2881835 | 767 | Geometric Coefficient of Variation 48 | nanograms*hour/milliliter (ng*hr/mL) | |
| Pharmacokinetics (PK): Area Under the Curve (AUC) of LY2881835 | Part B, Study Period 1 - 8.4 mg LY2881835 | 820 | Geometric Coefficient of Variation 20 | nanograms*hour/milliliter (ng*hr/mL) | |
| Pharmacokinetics (PK): Area Under the Curve (AUC) of LY2881835 | Part B, Study Period 2 - 8.4 mg LY2881835 | 683 | Geometric Coefficient of Variation 26 | nanograms*hour/milliliter (ng*hr/mL) | |
| Pharmacokinetics (PK): Area Under the Curve (AUC) of LY2881835 | Part B, Study Period 3 - 8.4 mg LY2881835 | 658 | Geometric Coefficient of Variation 43 | nanograms*hour/milliliter (ng*hr/mL) | |
| Pharmacokinetics (PK): Area Under the Curve (AUC) of LY2881835 | Part B, Study Periods 1, 2, and 3 - 8.4 mg LY2881835 | 717 | Geometric Coefficient of Variation 31 | nanograms*hour/milliliter (ng*hr/mL) | |
| Pharmacokinetics (PK): Maximum Concentration (Cmax) Of LY2881835 | Part A - 0.5 mg LY2881835 | 7.44 | Geometric Coefficient of Variation 16 | nanograms/milliliter (ng/mL) | |
| Pharmacokinetics (PK): Maximum Concentration (Cmax) Of LY2881835 | Part A - 1.5 mg LY2881835 | 14.7 | Geometric Coefficient of Variation 38 | nanograms/milliliter (ng/mL) | |
| Pharmacokinetics (PK): Maximum Concentration (Cmax) Of LY2881835 | Part A - 4.5 mg LY2881835 | 47.1 | Geometric Coefficient of Variation 25 | nanograms/milliliter (ng/mL) | |
| Pharmacokinetics (PK): Maximum Concentration (Cmax) Of LY2881835 | Part A - 8.4 mg LY2881835 | 89.9 | Geometric Coefficient of Variation 42 | nanograms/milliliter (ng/mL) | |
| Pharmacokinetics (PK): Maximum Concentration (Cmax) Of LY2881835 | Part B, Study Period 1 - 8.4 mg LY2881835 | 93.0 | Geometric Coefficient of Variation 30 | nanograms/milliliter (ng/mL) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01358981/results